How does sharewise work?
Discuss
Discuss and share predictions for your favorite stocks in the forum. Let your opinion be heard
Show moreTop Buy/Sell (This Month)
| Security | Price | Target price |
|---|---|---|
| NVIDIA Corp. | €181.34 | €215.58 |
| Amazon.com Inc. | €232.00 | €254.00 |
| Alphabet Inc. A | €326.05 | €336.43 |
| Security | Price | Target price |
|---|---|---|
| HP Inc. | €23.20 | €16.40 |
| Solar Capital Ltd | €11.15 | €11.48 |
| Southern Copper | €164.00 | €124.77 |
New Top predictions since last week
| Prediction | User | Perf. (%) |
|---|---|---|
| B Lenovo Group Ltd | RudolfL | 54.07% |
| B Redwood Ai Corp. | blaugold | 38.68% |
| B Okta Inc. | AlexanderDanielSchneider | 36.81% |
| Prediction | User | Perf. (%) |
|---|---|---|
| S Sivers Ima Holding Ab | quelbe60 | -22.98% |
| S X-FAB Silicon Foundries | Vassago1 | -17.91% |
| S Ideal Power Inc. | daimler1 | -17.83% |
Many tell you which stocks to buy.
We measure how often they are right!
Portfolios of our members
NEL ASA
When it comes to stocks, what is important for you?
Find stocks based on your criteria with our sharewise stock finder. All results are based on thousands of votes by our community
Pros and Cons of these stocks (New Predictions)
Stoke Therapeutics Inc
WKN: A2PLTL / Symbol: STOK / Name: Stoke Therapeutics / Stock / Biotechnology & Medical Research / ? /
Pros
Cons
Marubeni Corp
WKN: 860414 / Name: Marubeni / Stock / Diversified Trading & Distributing / Small Cap /
Pros
Cons
Try sharewise+ and get hundreds more matching stocks
Sign up for free!Tops & Flops S&P 500
| Security | Price | Change(%) (%) |
|---|---|---|
| NetApp Inc. | €149.10 | 21.680% |
| ServiceNow Inc. | €106.70 | 14.420% |
| International Business Machines Corp | €255.45 | 12.540% |
| Hewlett Packard Enterprise Co | €36.92 | 12.340% |
| Oracle Corp. | €193.50 | 10.670% |
| Security | Price | Change(%) (%) |
|---|---|---|
| Gap Inc. | €18.14 | -16.490% |
| Kohl's Corp. | €12.30 | -7.970% |
| Clorox Co. | €77.18 | -6.660% |
| Raymond James Financial | €125.00 | -6.420% |
| Capri Holdings Ltd. | €16.03 | -5.480% |
Courses
Get started on the stock market in these easy steps
Things you will learn:
- What is a stock
- What is a fund
- What is an ETF
- How to open a depot
- How to manage a depot that will regularly beat managed funds
- Why you mostly need patience to succeed on the stock market
sharewise advanced features
Also you get more information about our Pro and Cons feature, where we bring the wisdom of crowds to a new level.
For discussing with your friends and managing your investment clubs we will show you how to create your own stock debates.#
Predictions
Top News
Figure Technology Solutions Bets on Blockchain Rails to Reinvent Capital Markets
Key Points
- Interested in Figure Technology Solutions, Inc.? Here are five stocks we like better.
- Figure Technology Solutions says its long-term strategy is to build capital markets
Silvercorp Metals Q4 Earnings Call Highlights
Key Points
- Interested in Silvercorp Metals Inc.? Here are five stocks we like better.
- Record fourth-quarter results were driven by much higher silver prices, with revenue up 96% year over year
Evolv Technologies Highlights 45% Q1 Growth, Raised Outlook and AI Screening Push
Key Points
- Interested in Evolv Technologies Holdings, Inc.? Here are five stocks we like better.
- Evolv Technologies said first-quarter revenue rose 45% year over year to just over $46 million
Shares Fall, Targets Rise—Markets and Analysts Diverge on Synopsys
Key Points
- Interested in Synopsys, Inc.? Here are five stocks we like better.
- The performance of Synopsys shares has fallen far behind many other stocks in the AI trade.
- The company's latest
Salesforce Stock Finds Support as AI Momentum Builds
Key Points
- Interested in Salesforce Inc.? Here are five stocks we like better.
- Salesforce reported FQ1 net revenue of $11.31 billion, up 13.2% year-over-year, with adjusted earnings of $3.88
QBTS or RGTI: Which Quantum Stock Stands Out on $2B Federal Fund?
Pure-play quantum computing stocks received a strong boost on May 21 after the U.S. Department of Commerce announced letters of intent totaling approximately $2.013 billion in proposed CHIPS and
Best Stocks to Buy Before June 2026: 3 Breakout Stocks Ready to Surge
As June nears, investors may benefit from taking a more active approach to stock selection by identifying potential breakout opportunities within established price ranges. Under this strategy, a
3 Stocks to Watch as the SpaceX IPO Approaches (GILT, SATL, SATS)
SpaceX has officially filed its S-1 prospectus with the SEC, confirming plans to list on the Nasdaq under the ticker SPCX, with pricing expected on June 11 and public trading beginning as early as
AppLovin's Revenue Momentum Reflects AI-Driven Advertising Demand
AppLovin Corporation APP continues to showcase exceptional growth momentum, driven by rising demand for its AI-powered advertising and app monetization solutions. The company’s latest revenue
IBRX and the BCG Shortage: Deals That Could Expand Demand
ImmunityBio IBRX is trying to turn a persistent bottleneck in bladder cancer care into a durable demand driver. The long-running U.S. Bacillus Calmette-Guérin (BCG) shortage has created a structural
News
SoFi's Expanding Ecosystem Highlights Strong Growth Momentum
SoFi Technologies SOFI continues to demonstrate impressive growth across both its member base and product ecosystem, reinforcing the effectiveness of its innovation-led strategy and brand-building
IBRX Stock Outlook After Q1 Results and a New FDA Review
ImmunityBio IBRX enters the post-earnings stretch with the stock at $7.72 (as of May 28, 2026) and a six to12 month price target of $8.25. After a 289.9% year-to-date surge, the setup is less about
ImmunityBio: Anktiva Explained and What Comes Next
ImmunityBio IBRX is building a portfolio of immunotherapies designed to activate both innate and adaptive immunity in cancer and infectious diseases. Its Cancer BioShield platform centers on Anktiva
Gap Q1 Earnings Miss Estimates, Comparable Sales Rise 2% Y/Y
The Gap, Inc. GAP delivered adjusted earnings of 38 cents per share in the first quarter of fiscal 2026, down 25.5% year over year and missing the Zacks Consensus Estimate of 39 cents. Net sales of
MongoDB Q1 Earnings & Revenues Surpass Estimates, Increases Y/Y
MongoDB, Inc.MDB delivered first-quarter fiscal 2027 non-GAAP earnings of $1.32 per share, up 32% year over year and beating the Zacks Consensus Estimate by 11.86%.Total revenues increased 25.3%
ADSK Q1 Earnings Beat, Revenues Rise Y/Y on Broad-Based Construction
Autodesk, Inc.ADSK delivered a strong first-quarter fiscal 2027 performance, with non-GAAP earnings of $2.99 per share, up 30.6% year over year. The figure surpassed the Zacks Consensus Estimate of
GitLab Set to Report Q1 Earnings: What's in Store for the Stock?
GitLab GTLB is set to release its first-quarter fiscal 2027 results on June 2, 2026.The company expects first-quarter fiscal 2027 revenues between $253 million and $255 million, indicating
SentinelOne Q1 Earnings Beat, Revenues Increase Y/Y, Shares Rise
SentinelOne S reported first-quarter fiscal 2027 earnings of 4 cents per share, which surpassed the Zacks Consensus Estimate by 100%. The company registered earnings of 2 cents per share in the
Cenovus Ramps Up Christina Lake North Asset to Drive Future Output
Cenovus Energy CVE is an integrated energy company based in Canada, with operations spanning upstream and downstream segments. The company’s upstream segment recorded strong production volumes of
Contest
Still running
Leeway
Die Analyse-Plattform Leeway untersucht mit KI-unterstützten Algorithmen aussagekräftige Zusammenhänge am Aktienmarkt. Anhand von vielen Millionen Datenpunkten finden die Algorithmen die Kennzahlen und Bewegungen, die nachweisbare Auswirkungen haben und Vorteile schaffen.
Kostenlos ausprobierensharewise
Du findest das sharewise Projekt spannend und möchtest es unterstützen?
Mit einer
sharewise+-Mitgliedschaft
unterstützt du uns finanziell und bekommst zusätzliche Funktionalitäten freigeschalten.
Heibel Ticker
sharewise sagt: Stephan Heibel ist ein langähriger Unterstützer und Autor der Wunschanalyse. Er betreibt meiner Meinung nach einen der besten Börsenbriefe. Es gibt eine kostenlose und eine Premium Variante.
Kostenlos ausprobierensharewise
Du findest das sharewise Projekt spannend und möchtest es unterstützen?
Mit einer
sharewise+-Mitgliedschaft
unterstützt du uns finanziell und bekommst zusätzliche Funktionalitäten freigeschalten.